Previous studies have identified CXCL4 (also called platelet factor 4, or PF-4), derived from α-granules of activated degranulated platelets, as a “broad-spectrum” inhibitor of HIV-1 infection of T cells [45], [42]. This evidence concerns the gene PF4 and HIV-1 infection.